Surgical & Medical Instruments & Apparatus
Standard Industrial Classification: SIC 3841
Industry Insider Sentiment Analysis
The Surgical & Medical Instruments & Apparatus sector (SIC 3841) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2015-02-06 02:18 | 2015-02-05 | ICUI | ICU MEDICAL INC/DE | SAUCEDO JOSEPH R | Director | SELL | $83.53 | 1,875 | $156,619 | 940 |
| 2015-02-05 00:26 | 2015-02-02 | SYK | STRYKER CORP | Benscoter Steven P | Officer | SELL | $90.60 | 3,821 | $346,185 | 4,925 |
| 2015-02-05 04:36 | 2015-02-02 | RMD | RESMED INC | FARRELL PETER C | Director, Officer | OPT+S | $61.97 | 36,000 | $2,230,772 | 167,864 |
| 2015-02-05 05:18 | 2015-02-02 | DXCM | DEXCOM INC | MOY JEFFREY | Officer | OPT+S | $60.69 | 5,000 | $303,425 | 82,964 |
| 2015-02-04 02:28 | 2015-02-02 | TNDM | TANDEM DIABETES CARE INC | Sheridan John F | Officer | OPT+S | $12.06 | 2,000 | $24,127 | 2,235 |
| 2015-02-03 20:22 | 2015-02-02 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | Director, Officer | OPT+S | $39.15 | 4,765 | $186,530 | 147,040 |
| 2015-02-04 05:02 | 2015-01-30 | LMAT | LEMAITRE VASCULAR INC | Gebauer Peter R | Officer | OPT+S | $7.92 | 11,281 | $89,361 | 41,866 |
| 2015-02-04 02:37 | 2015-01-31 | ARAY | Accuray Incorporated | Nouri Alaleh | Officer | SELL | $7.38 | 5,164 | $38,110 | 68,815 |
| 2015-02-03 04:31 | 2015-02-02 | ICUI | ICU MEDICAL INC/DE | LOPEZ GEORGE A | Director, 10% owner | SELL | $83.25 | 30,000 | $2,497,527 | 400,716 |
| 2015-01-31 05:28 | 2015-01-28 | LMAT | LEMAITRE VASCULAR INC | Gebauer Peter R | Officer | OPT+S | $7.91 | 16,919 | $133,779 | 41,866 |
| 2015-01-29 04:24 | 2015-01-26 | RMD | RESMED INC | PACE GARY W | Director | OPT+S | $66.77 | 48,000 | $3,204,816 | 93,158 |
| 2015-01-29 04:25 | 2015-01-26 | RMD | RESMED INC | TAYLOR RONALD R | Director | OPT+S | $66.98 | 36,000 | $2,411,316 | 35,471 |
| 2015-01-29 00:10 | 2015-01-26 | LMAT | LEMAITRE VASCULAR INC | Gebauer Peter R | Officer | OPT+S | $7.90 | 1,800 | $14,220 | 41,866 |
| 2015-01-29 00:09 | 2015-01-26 | LMAT | LEMAITRE VASCULAR INC | LeMaitre George W | Director, Officer, 10% owner | SELL | $7.85 | 3,486 | $27,360 | 4,031,160 |
| 2015-01-29 05:10 | 2015-01-26 | DXCM | DEXCOM INC | Balo Andrew K | Officer | OPT+S | $59.25 | 15,001 | $888,739 | 150,130 |
| 2015-01-28 03:41 | 2015-01-23 | DXCM | DEXCOM INC | DOUBLEDAY RICHARD | Officer | OPT+S | $58.22 | 4,000 | $232,864 | 119,950 |
| 2015-01-28 03:33 | 2015-01-23 | DXCM | DEXCOM INC | Pacelli Steven Robert | Officer | OPT+S | $59.67 | 24,532 | $1,463,812 | 228,866 |
| 2015-01-27 00:39 | 2013-10-15 | BAX | BAXTER INTERNATIONAL INC | STROUCKEN ALBERT P L | Director | BUY | $67.52 | 696 | $46,993 | 696 |
| 2015-01-23 05:03 | 2015-01-20 | DXCM | DEXCOM INC | ROPER JESS | Officer | OPT+S | $57.34 | 7,000 | $401,355 | 81,342 |
| 2015-01-23 04:54 | 2015-01-20 | DXCM | DEXCOM INC | MOY JEFFREY | Officer | OPT+S | $57.58 | 5,000 | $287,906 | 82,292 |
| 2015-01-23 02:53 | 2015-01-20 | NUOT | Nuo Therapeutics, Inc. | Aldagen Holdings, LLC | 10% owner | SELL | $0.35 | 5,500 | $1,925 | 12,181,395 |
| 2015-01-21 00:06 | 2015-01-20 | BSX | BOSTON SCIENTIFIC CORP | Phalen Michael P. | Officer | SELL | $14.54 | 10,000 | $145,407 | 108,645 |
| 2015-01-21 02:53 | 2015-01-15 | DXCM | DEXCOM INC | GREGG TERRANCE H | Director, Officer | SELL | $57.84 | 15,000 | $867,561 | 581,389 |
| 2015-01-16 00:52 | 2015-01-13 | NUOT | Nuo Therapeutics, Inc. | Aldagen Holdings, LLC | 10% owner | SELL | $0.35 | 167,467 | $58,613 | 12,186,895 |
| 2015-01-15 02:36 | 2015-01-12 | DXCM | DEXCOM INC | Pacelli Steven Robert | Officer | OPT+S | $60.16 | 29,468 | $1,772,680 | 228,866 |
| 2015-01-14 19:02 | 2015-01-13 | ICUI | ICU MEDICAL INC/DE | SHERMAN RICHARD MD | Director | SELL | $85.00 | 8,500 | $722,500 | 67,791 |
| 2015-01-13 04:49 | 2015-01-08 | DXCM | DEXCOM INC | VALDES JORGE A | Officer | OPT+S | $57.55 | 9,170 | $527,693 | 74,609 |
| 2015-01-13 04:36 | 2015-01-08 | DXCM | DEXCOM INC | LISTER JOHN | Officer | OPT+S | $57.42 | 5,039 | $289,337 | 110,018 |
| 2015-01-13 05:09 | 2015-01-08 | NUOT | Nuo Therapeutics, Inc. | Aldagen Holdings, LLC | 10% owner | SELL | $0.35 | 217,383 | $76,084 | 12,354,362 |
| 2015-01-10 00:14 | 2015-01-08 | BSX | BOSTON SCIENTIFIC CORP | Pierce David A | Officer | SELL | $14.31 | 18,612 | $266,327 | 33,161 |
| 2015-01-10 00:15 | 2015-01-08 | BSX | BOSTON SCIENTIFIC CORP | Phalen Michael P. | Officer | SELL | $14.31 | 27,589 | $394,782 | 118,645 |
| 2015-01-08 01:50 | 2015-01-05 | DXCM | DEXCOM INC | MOY JEFFREY | Officer | OPT+S | $55.27 | 5,000 | $276,368 | 82,292 |
| 2015-01-07 00:17 | 2015-01-05 | BSX | BOSTON SCIENTIFIC CORP | Phalen Michael P. | Officer | SELL | $13.75 | 10,000 | $137,500 | 146,234 |
| 2015-01-06 21:09 | 2014-12-31 | VYCO | VYCOR MEDICAL INC | FOUNTAINHEAD CAPITAL MANAGEMENT LTD | 10% owner | BUY | $1.79 | 8,380 | $15,000 | 4,366,844 |
| 2015-01-06 21:52 | 2015-01-02 | RMD | RESMED INC | Douglas Robert Andrew | Officer | OPT+S | $56.99 | 8,000 | $455,925 | 58,624 |
| 2015-01-06 21:41 | 2015-01-02 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | Director, Officer | OPT+S | $37.20 | 4,765 | $177,252 | 147,040 |
| 2015-01-06 22:29 | 2015-01-05 | RMD | RESMED INC | PENDARVIS DAVID | Officer | OPT+S | $57.09 | 5,500 | $313,987 | 70,091 |
| 2015-01-06 20:41 | 2015-01-02 | RMD | RESMED INC | FARRELL PETER C | Director, Officer | OPT+S | $56.99 | 36,000 | $2,051,640 | 167,864 |
| 2015-01-07 01:33 | 2015-01-02 | PODD | INSULET CORP | LIAMOS CHARLES T | Director | OPT+S | $46.08 | 4,000 | $184,320 | 100,733 |
| 2015-01-07 02:11 | 2015-01-06 | ICUI | ICU MEDICAL INC/DE | LOPEZ GEORGE A | Director, 10% owner | SELL | $80.90 | 13,600 | $1,100,297 | 398,035 |
| 2015-01-06 00:51 | 2015-01-02 | TNDM | TANDEM DIABETES CARE INC | Sheridan John F | Officer | OPT+S | $12.75 | 2,000 | $25,501 | 2,235 |
| 2015-01-06 00:22 | 2015-01-02 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP | OGRADY JUDITH | Officer | SELL | $53.33 | 3,500 | $186,642 | 7,206 |
| 2015-01-06 04:23 | 2014-12-31 | LMAT | LEMAITRE VASCULAR INC | LeMaitre George W | Director, Officer, 10% owner | SELL | $7.74 | 18,447 | $142,763 | 4,034,646 |
| 2015-01-06 04:17 | 2015-01-02 | LMAT | LEMAITRE VASCULAR INC | Roberts David B | Director, Officer | SELL | $7.31 | 7,000 | $51,195 | 193,210 |
| 2015-01-06 02:54 | 2015-01-05 | ICUI | ICU MEDICAL INC/DE | LOPEZ GEORGE A | Director, 10% owner | SELL | $80.75 | 16,400 | $1,324,331 | 398,035 |
| 2015-01-03 00:18 | 2014-12-31 | ATRC | AtriCure, Inc. | Hooven Michael D | Director | SELL | $20.00 | 57,732 | $1,154,640 | 305,345 |
| 2015-01-03 05:24 | 2014-12-31 | NUOT | Nuo Therapeutics, Inc. | Aldagen Holdings, LLC | 10% owner | SELL | $0.35 | 100 | $35 | 12,571,745 |
| 2015-01-03 00:18 | 2014-12-31 | MELA | STRATA Skin Sciences, Inc. | Cook Robert W. | Officer | BUY | $1.23 | 10,000 | $12,294 | 10,000 |
| 2015-01-01 04:38 | 2014-12-30 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $95.95 | 14,000 | $1,343,311 | 10,195,682 |
| 2014-12-31 23:51 | 2014-12-29 | NUOT | Nuo Therapeutics, Inc. | Aldagen Holdings, LLC | 10% owner | SELL | $0.35 | 300,000 | $105,000 | 12,571,845 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Surgical & Medical Instruments & Apparatus sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (3841) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Surgical & Medical Instruments & Apparatus
Every transaction in the Surgical & Medical Instruments & Apparatus industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.